文献
J-GLOBAL ID:201802260986837602
整理番号:18A2086637
α-ガラクトシダーゼAおよびグロボトリアオシルスフィンゴシンの測定による日本の若年発症脳卒中患者におけるFabry病のスクリーニング
Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine
著者 (18件):
Kinoshita Naoto
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Hosomi Naohisa
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Matsushima Hayato
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Matsushima Hayato
(Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan)
,
Nakamori Masahiro
(Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan)
,
Yagita Yoshiki
(Department of Stroke Medicine, Kawasaki Medical School, Kurashiki, Japan)
,
Yamawaki Takemori
(Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan)
,
Torii Tsuyoshi
(Department of Neurology, National Hospital Organization Kure Medical Center, Kure, Japan)
,
Kitamura Takeshi
(Department of Neurology, Chugoku Rosai Hospital, Kure, Japan)
,
Sueda Yoshimasa
(Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan)
,
Shimomura Ryo
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Araki Mutsuko
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Nezu Tomohisa
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Aoki Shiro
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Ishii Satoshi
(GlycoPharma Corporation, Oita, Japan)
,
Maruyama Hiroki
(Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
,
Matsumoto Masayasu
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
,
Maruyama Hirofumi
(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan)
資料名:
Journal of Stroke & Cerebrovascular Diseases
(Journal of Stroke & Cerebrovascular Diseases)
巻:
27
号:
12
ページ:
3563-3569
発行年:
2018年12月
JST資料番号:
W1420A
ISSN:
1052-3057
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)